ECM
WST icon

Everence Capital Management’s West Pharmaceutical WST Stock Holding History

Everence Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,525
Closed -$695K – 908
2025
Q4 		$695K Buy
2,525
+1,110
+78% +$304K 0.04% 307
2025
Q3 		$371K Buy
+1,415
New +$344K 0.02% 503
2025
Q2 		– Sell
-3,040
Closed -$681K – 854
2025
Q1 		$681K Buy
+3,040
New +$838K 0.05% 295
2024
Q4 		– Sell
-2,130
Closed -$639K – 1050
2024
Q3 		$639K Hold
2,130
– – 0.04% 346
2024
Q2 		$761 Hold
2,130
– – 0.05% 271
2024
Q1 		$843 Sell
2,130
-1,150
-35% -$425K 0.06% 267
2023
Q4 		$1.16M Buy
3,280
+2,020
+160% +$715K 0.08% 205
2023
Q3 		$473 Hold
1,260
– – 0.04% 400
2023
Q2 		$422K Hold
1,260
– – 0.03% 402
2023
Q1 		$437 Hold
1,260
– – 0.04% 408
2022
Q4 		$297 Sell
1,260
-1,230
-49% -$291K 0.03% 551
2022
Q3 		$613K Hold
2,490
– – 0.06% 289
2022
Q2 		$753K Hold
2,490
– – 0.07% 237
2022
Q1 		$1.02M Hold
2,490
– – 0.08% 206
2021
Q4 		$1.17M Hold
2,490
– – 0.09% 197
2021
Q3 		$1.06M Hold
2,490
– – 0.09% 192
2021
Q2 		$894K Hold
2,490
– – 0.07% 224
2021
Q1 		$702K Hold
2,490
– – 0.06% 252
2020
Q4 		$705K Buy
2,490
+1,060
+74% +$297K 0.07% 240
2020
Q3 		$393K Buy
+1,430
New +$378K 0.04% 368

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Everence Capital Management's WST Position: Q1 2026 in Review

Everence Capital Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 2,525 shares — an estimated $695K sold.

Everence Capital Management first reported a position in WST in Q3 2020 and held it in 20 quarters. The position peaked at $1.17M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Everence Capital Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Everence Capital Management sold 2,525 West Pharmaceutical shares in Q1 2026, an estimated $695K.
  • Everence Capital Management first reported a position in West Pharmaceutical in Q3 2020 and held it in 20 quarters.
  • Everence Capital Management's West Pharmaceutical position peaked at $1.17M in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.